Form 483

Apotex Inc. Form 483, 2017-06-14

FDA issued a Form 483 to Apotex Inc. on 2017-06-14 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

Apotex Inc. · North York, Canada · Issued June 14, 2017

Overview

  • 4 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

14 Jun 2017
21 CFR 211.67(b)(2)

Cleaning SOPs/schedules

Cited by Laurimer Kuilan-Torres, Hala L Selby

14 Jun 2017
21 CFR 211.67(b)(2)

Cleaning SOPs/schedules

Cited by Laurimer Kuilan-Torres, Hala L Selby

14 Jun 2017
21 CFR 211.68(b)

Backup file not maintained

Cited by Laurimer Kuilan-Torres, Hala L Selby

14 Jun 2017
21 CFR 211.68(b)

Backup file not maintained

Cited by Laurimer Kuilan-Torres, Hala L Selby

Inspected site

AIApotex Inc.North York, Canada

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.67(b)(2)Cited across public-safe Form 483 observations2x
21 CFR 211.68(b)Cited across public-safe Form 483 observations2x

Full 483 report

Get the verbatim text of all 4 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere